← Insider buys
ACRS

Aclaris Therapeutics, Inc. · Healthcare

CFO Frank Ruffo sold $2.3M of Aclaris Therapeutics, Inc.

Sold$2,310,106
$26.45Price
87,339Shares
−37%Stake

What ACRS did after the filing

Prices for ACRS after this filing aren't in yet.

Traded Thu, Apr 22. Filed Mon, Apr 26, 5:45 PM ET, after the close. Not investment advice.